Duloxetine for the treatment of obsessive compulsive disorder

Trial Profile

Duloxetine for the treatment of obsessive compulsive disorder

Phase of Trial: Phase IV

Latest Information Update: 09 Mar 2017

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Obsessive-compulsive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 23 Apr 2013 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 19 Jul 2011 Planned End Date changed from 1 Aug 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top